Conclusion Shuxuening injection was effective for treating acute cerebral infarction, probably by decreasing the CRP and TXB2 levels in plasma.
结论舒血宁注射液治疗急性脑梗死的疗效可能与使急性脑梗死患者血浆CRP和TXB2水平下降有关。
2
Method Plasma 11-dehydrothromboxane B2(DH-TXB2) and thromboxane B2(TXB2) were detected using ELISA in 38 PIH patients and 20 normal non-pregnant women.
From this trial, it was indicated that acti's reducing thrombosis action was the result of inhibiting aggregation and releasing of platelets through reducing whole blood viscosities and TXB2 level.